Celecoxib suppresses fibroblast proliferation and collagen expression by inhibiting ERK1/2 and SMAD2/3

Fengfeng Li1, Cunyi Fan, Bingfang Zeng

  • 1Department of Orthopaedics, The Sixth Affiliated People's Hospital, Shanghai Jiaotong University, Shanghai 200233, PR China.

Molecular Medicine Reports
|December 28, 2011
PubMed

Insights

Celecoxib inhibits fibroblast proliferation and collagen production by blocking key signaling pathways. This study demonstrates celecoxib

Area of Science:

  • Cell Biology
  • Pharmacology

Background:

  • Fibroblast proliferation and collagen expression are critical in wound healing and fibrosis.
  • Extracellular signal-regulated kinase 1/2 (ERK1/2) and SMAD2/3 pathways regulate these processes.
  • Understanding how drugs modulate these pathways is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the effects of celecoxib on fibroblast proliferation and collagen expression.
  • To determine if celecoxib inhibits these processes by modulating ERK1/2 and SMAD2/3 phosphorylation.

Main Methods:

  • NIH/3T3 fibroblasts were stimulated with fibroblast growth factor-2 (FGF-2) or transforming growth factor-β1 (TGF‑β1).
  • Celecoxib's effects on cell proliferation, viability, and apoptosis were assessed using MTT assays.
  • Quantitative RT-PCR and Western blot analysis were used to measure ERK1/2 and SMAD2/3 expression and phosphorylation.

Main Results:

  • Celecoxib suppressed FGF-2-stimulated fibroblast proliferation and viability.
  • Celecoxib induced apoptosis in NIH/3T3 fibroblasts.
  • Celecoxib inhibited TGF‑β1-stimulated collagen expression by reducing SMAD2/3 phosphorylation.
  • Celecoxib inhibited ERK1/2 phosphorylation, impacting fibroblast proliferation.

Conclusions:

  • Celecoxib effectively suppresses fibroblast proliferation and collagen expression.
  • The mechanism involves the inhibition of ERK1/2 and SMAD2/3 phosphorylation.
  • These findings suggest potential therapeutic applications for celecoxib in conditions involving excessive fibroblast activity.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...